|
|
|
Manel Pladevall, MD, MSc
Investigator
Contact Information:
Email: mpladev1@hfhs.org
Phone: (313) 874-5454
Fax: (313) 874-7137
Recent Publications:
Nau D,
Steinke D, Williams LK, Austin R,
Elston Lafata J,
Divine G,
Pladevall
M.
Adherence Analysis Using Visual Analog Scale Versus Claims-Based
Estimation. Annals of Pharmacotherapy Epub 2007 October 9.
Simpkins J,
Divine G, Wang M, Holmboe E,
Pladevall M,
Williams LK.
Improving asthma care through recertification: a cluster
randomized trial. Arch of Intern Med. 2007 Nov 12;
167(20):2240-8.
Tunceli
K,
Bradley CJ, Elston
Lafata J, Pladevall M,
Goodman AC,
Divine
G, Vijan S.
Glycemic Control and Absenteeism among Individuals with
Diabetes. Diabetes Care 2007 May;30(5):1283-5.
Williams LK,
CL Joseph, EL Peterson,
C Moon,
H Xi, R Krajenta, R Johnson, K Wells, JC Booza,
K
Tunceli,
JE Lafata,
CC Johnson, DR Ownby, R Enberg,
M Pladevall.
Race-ethnicity, crime, and other factors associated with
adherence to inhaled corticosteroids. Journal of Allergy
and Clinical Immunology
2007 Jan;119(1):168-75; Epub 2006 Nov 2
Williams LK,
Joseph CL, Peterson EL, Wells K, Wang M, Chowdhry VK, Walsh M,
Campbell J, Rand CS, Apter AJ, Lanfear DE,
Tunceli K,
Pladevall M.
Patients with asthma who do not fill their inhaled
corticosteroids: a study of primary non-adherence. J Allergy
Clin Immunol 2007 Nov;120(5):1153-9. Epub 2007 Oct 22.
Biography:
Dr. Manel Pladevall-Vila received an MD in 1982 form the
Autonomous Barcelona University in Spain. He did his residency
in Internal Medicine and fellowship in Hypertension at Vic
General Hospital (Barcelona, Spain). He received and MS degree
in epidemiology from the University of Texas in 1992. Dr. Manel
Pladevall-Vila serves since February 2002 as Research Scientist
for the Center for Health Services Research at the Henry Ford
Health System in Detroit, MI. Dr. Pladevall's main research
interests are in the cardiovascular area. He has been the
principal investigator of two epidemiological studies on the
epidemiology of the metabolic Syndrome, funded by the Spanish
government. While in Spain, he participated in several clinical
trials in the cardiovascular area and was an active member of
the Spanish Cochrane Collaboration. He currently is the
principal investigator of another Spanish funded study, a
multi-center cluster randomized trail of an intervention to
improve adherence to blood pressure lowering drugs in patients
at high cardiovascular risk. Among his latest areas of research
are the usefulness of claims data to measure adherence and the
association between levels of adherence and clinical outcomes.
|